Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Improving performance of docking-based virtual screening by structural filtration.

Fedor N Novikov1, Viktor S Stroylov, Oleg V Stroganov

  • 1MolTech Ltd, 119992, Moscow, Leninskie gory, 1/75A, Russia.

Journal of Molecular Modeling
|December 31, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors.

Nature cancer·2024
Same author

Quantum Mechanical-Cluster Approach to Solve the Bioisosteric Replacement Problem in Drug Design.

Journal of chemical information and modeling·2023
Same author

Clinical CDK2 Inhibitors: Trends to Selectivity and Efficacy.

Recent patents on anti-cancer drug discovery·2022
Same author

A New Class of Uracil-DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme.

Molecules (Basel, Switzerland)·2021
Same author

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin.

European journal of medicinal chemistry·2020
Same author

The role of human in the loop: lessons from D3R challenge 4.

Journal of computer-aided molecular design·2020
Same journal

Identification of potential inhibitors of dengue virus ns5 methyltransferase and polymerase domains through virtual screening and molecular dynamics studies.

Journal of molecular modeling·2026
Same journal

Mechanisms of the binding of camptothecin derivatives with topoisomerase I: Molecular docking, molecular dynamics simulations, and binding free energy calculations.

Journal of molecular modeling·2026
Same journal

Electronic structure modeling of transition metal hyperdoping in β-Ga<sub>2</sub>O<sub>3</sub>: concentration-dependent band hybridization and optoelectronic tuning.

Journal of molecular modeling·2026
Same journal

Electronic effects on the stability of heteroleptic nickel(II) complexes with aromatic and aliphatic ligands.

Journal of molecular modeling·2026
Same journal

Effects of Zn doping on the mechanical and thermoelectric properties of calcium silicate hydrate.

Journal of molecular modeling·2026
Same journal

The influence mechanism of moisture content on lignite methane adsorption under deep high-temperature and high-pressure conditions: a molecular simulation perspective.

Journal of molecular modeling·2026
See all related articles

This study introduces structural filtration to enhance virtual screening accuracy. This method improves drug discovery by reducing false positives and negatives in molecular docking.

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Virtual screening methods often suffer from scoring function deficiencies.
  • These deficiencies can lead to overestimation of decoy binding and a high false positive rate.
  • Protein structure model inaccuracies can also result in false negative predictions.

Purpose of the Study:

  • To introduce and evaluate an innovative structural filtration method for improving virtual screening results.
  • To address limitations in current virtual screening scoring functions and protein structure models.
  • To enhance the accuracy and efficiency of identifying potential drug candidates.

Main Methods:

  • Developed protein-specific structural filters based on conserved, crucial protein-ligand interactions.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Related Experiment Videos

Last Updated: Jun 17, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

  • Applied these filters to virtual screening results obtained using Lead Finder software.
  • Evaluated the method on 10 diverse protein targets.
  • Main Results:

    • Structural filtration significantly improved the enrichment factor, ranging from several-fold to hundreds-fold increases.
    • The method effectively corrected scoring function overestimations of decoy binding, lowering the false positive rate.
    • Structural filters also mitigated false negatives arising from protein structure model deficiencies.

    Conclusions:

    • Structural filtration is an effective technique for enhancing virtual screening accuracy.
    • This approach shows promise for fragment-based drug discovery by identifying specifically bound small molecules.
    • The method offers a valuable tool for improving the reliability of computational drug discovery pipelines.